obesity drug news today glp-1 october 2025 Exploring the Side Effects of GLP -1 Receptor obesity drug news today glp-1

GLP1 receptor agonists (GLP-1s) are prescription drugs widely used to manage type 2 diabetes, obesity and related chronic conditions such as cardiovascular disease and fatty liver disease

By lowering both, GLP-1s may help preserve fertility in ways unrelated to weight loss or insulin sensitivity

References 1.Zhang Y, et al

High-intensity interval training (HIIT) has gained attention for metabolic benefits achieved in shorter durations

If you are sitting there, like I was, wondering if you have or have had either of these conditions, I can assure you that you would probably know as a specialist has likely told you so

7679 Additionally, in a mouse model of colitis, mice with elevated DPP4 levels exhibited higher levels of vasoactive intestinal peptide (VIP), IL-6, and neuropeptide Y (NPY), all of which are substrates of DPP4